An observational study in Acute Appendicitis, sponsored by Kecheng Zhang. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-06.
Sponsored by Kecheng Zhang · Observational
Non-operative management (NOM) with antibiotics may be a safe alternative to surgery for uncomplicated appendicitis, but preoperative differentiation between uncomplicated and complicated appendicitis is challenging. The study aimed to develop a clinical-radiomics nomogram to distinguish uncomplicated from complicated appendicitis.
412 studies on the registry are indexed under Appendicitis; 62 are open to participants now.
This study's planned enrollment of 250 is above the median of 200 across 150 observational studies indexed under Appendicitis.
Browse Appendicitis studies →This is the only study on the registry with Kecheng Zhang as lead sponsor.
Counted across the registry records on this site, refreshed daily.
All adults with pathologically diagnosed as acute appendicitis after appendectomy
Exclusion Criteria:
Model construction based on training cohort
Diagnostic Test: without
Model validation in an independent validation cohort 1
Diagnostic Test: without
Model validation in an independent validation cohort 2
Diagnostic Test: without
without
Accuracy of clinical-radiomic model for differentiating complicated from uncomplicated appendicitis
ROC curve will be plotted and the area under ROC curve will be compared
Time frame: January 2021 to December 2022
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.